Literature DB >> 23543532

Antibiotics for brain abscesses in people with cyanotic congenital heart disease.

Pagakrong Lumbiganon1, Arnkisa Chaikitpinyo.   

Abstract

BACKGROUND: Brain abscess is a focal, intracerebral infection that begins as a localized area of brain infection and develops into a collection of pus surrounded by a well-vascularized capsule. People with cyanotic congenital heart disease are at risk of developing brain abscess.
OBJECTIVES: To evaluate the effectiveness of antibiotic regimens for treating brain abscess in people with cyanotic congenital heart disease. SEARCH
METHODS: We updated the searches of the Cochrane Central Register of Controlled Trials (CENTRAL) on The Cochrane Library Issue 12 of 12, December 2012, MEDLINE Ovid (1946 to December Week 4 2012), EMBASE Ovid (1980 to 2013 Week 01) and LILACS (1980 to 9 January 2013) on 9 January 2013. No language or publication restrictions were applied. SELECTION CRITERIA: Randomized controlled trials that reported clinically meaningful outcomes and presented results on an intention to treat basis, irrespective of blinding, publication status, or language. DATA COLLECTION AND ANALYSIS: Data were to be extracted, unblinded, by the two reviewers independently. MAIN
RESULTS: No studies meeting the inclusion criteria were identified. AUTHORS'
CONCLUSIONS: There are no randomized controlled trials about the effectiveness of antibiotic regimens for treating people with cyanotic congenital heart disease who developed a brain abscess. Currently, the antibiotic regimens used are based on previous retrospective studies and clinical experience. There is a need for a well designed multicentre randomized controlled trial to evaluate the effects of different antibiotic regimens.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23543532      PMCID: PMC7197203          DOI: 10.1002/14651858.CD004469.pub3

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  33 in total

Review 1.  Systematic reviews in health care: Assessing the quality of controlled clinical trials.

Authors:  P Jüni; D G Altman; M Egger
Journal:  BMJ       Date:  2001-07-07

2.  Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses.

Authors:  L L Kjaergard; J Villumsen; C Gluud
Journal:  Ann Intern Med       Date:  2001-12-04       Impact factor: 25.391

3.  Efficacy and safety of cefotaxime in combination with metronidazole for empirical treatment of brain abscess in clinical practice: a retrospective study of 66 consecutive cases.

Authors:  A-K Jansson; P Enblad; J Sjölin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-12-11       Impact factor: 3.267

4.  Bacterial brain abscess: microbiological features, epidemiological trends and therapeutic outcomes.

Authors:  C-H Lu; W-N Chang; Y-C Lin; N-W Tsai; P-C Liliang; T-M Su; C-S Rau; Y-D Tsai; C-L Liang; C-J Chang; P-Y Lee; H-W Chang; J-J Wu
Journal:  QJM       Date:  2002-08

5.  Assessing the quality of reports of randomized clinical trials: is blinding necessary?

Authors:  A R Jadad; R A Moore; D Carroll; C Jenkinson; D J Reynolds; D J Gavaghan; H J McQuay
Journal:  Control Clin Trials       Date:  1996-02

Review 6.  Brain abscess.

Authors:  G E Mathisen; J P Johnson
Journal:  Clin Infect Dis       Date:  1997-10       Impact factor: 9.079

7.  Bias in meta-analysis detected by a simple, graphical test.

Authors:  M Egger; G Davey Smith; M Schneider; C Minder
Journal:  BMJ       Date:  1997-09-13

8.  Brain abscesses in cyanotic heart disease.

Authors:  G K Prusty
Journal:  Indian J Pediatr       Date:  1993 Jan-Feb       Impact factor: 1.967

9.  Trends in the management of bacterial brain abscesses: a review of 102 cases over 17 years.

Authors:  T J Mampalam; M L Rosenblum
Journal:  Neurosurgery       Date:  1988-10       Impact factor: 4.654

10.  Penetration of cefotaxime and desacetylcefotaxime into brain abscesses in humans.

Authors:  J Sjölin; N Eriksson; P Arneborn; O Cars
Journal:  Antimicrob Agents Chemother       Date:  1991-12       Impact factor: 5.191

View more
  7 in total

1.  Bacterial brain abscess.

Authors:  Kevin Patel; David B Clifford
Journal:  Neurohospitalist       Date:  2014-10

2.  Pyogenic brain abscess and subdural empyema: presentation, management, and factors predicting outcome.

Authors:  John D Widdrington; Helena Bond; Ulrich Schwab; D Ashley Price; Matthias L Schmid; Brendan McCarron; David R Chadwick; Manjusha Narayanan; John Williams; Edmund Ong
Journal:  Infection       Date:  2018-07-27       Impact factor: 3.553

3.  Anaerobic brain abscess.

Authors:  Sukanya Sudhaharan; Padmasri Chavali; Lakshmi Vemu
Journal:  Iran J Microbiol       Date:  2016-04

4.  Precision diagnosis and therapy of a case of brain abscesses associated with asymptomatic pulmonary arteriovenous fistulas.

Authors:  Lu-Yao Gao; Guang-Run Xu; Ting-Jun Dai
Journal:  BMC Infect Dis       Date:  2020-05-24       Impact factor: 3.090

Review 5.  Intramedullary spinal cord abscess associated with right-to-left shunt via right superior vena cava draining into left atrium: A case report.

Authors:  Satoshi Hirose; Naohiro Sudo; Masahiro Okada; Naotoshi Natori; Takayoshi Akimoto; Makoto Hara; Hideto Nakajima
Journal:  Medicine (Baltimore)       Date:  2022-07-01       Impact factor: 1.817

6.  [Brain abscess complicating congenital heart disease: report of 7 cases at the Abidjan Heart Institute].

Authors:  Yves N'da Kouakou N'goran; Micesse Tano; Fatoumata Traore; Inès Angoran; N'guetta Roland; Aké Evelyne Traboulsi; Konan Serge Yao; Kouadio Euloge Kramoh; Maurice Guikahue Kakou
Journal:  Pan Afr Med J       Date:  2015-10-08

7.  Cerebral Abscess Associated With Odontogenic Bacteremias, Hypoxemia, and Iron Loading in Immunocompetent Patients With Right-to-Left Shunting Through Pulmonary Arteriovenous Malformations.

Authors:  Emily J Boother; Sheila Brownlow; Hannah C Tighe; Kathleen B Bamford; James E Jackson; Claire L Shovlin
Journal:  Clin Infect Dis       Date:  2017-08-15       Impact factor: 9.079

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.